These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27277656)

  • 1. Correspondence Letter to the Editor regarding 'The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex' by Langley, McFadzean & McCormack.
    Ekeoduru R; Lin M; Matuszczak M
    Paediatr Anaesth; 2016 Jul; 26(7):773-4. PubMed ID: 27277656
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Ekeoduru, Rhashedah; Matuszczak, Maria; Lin, Michael, regarding their comment 'Correspondence' regarding 'The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex' by Langley, McFadzean & McCormack.
    McCormack JG; Langley R; McFadzean J
    Paediatr Anaesth; 2016 Aug; 26(8):855-6. PubMed ID: 27370521
    [No Abstract]   [Full Text] [Related]  

  • 3. The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex.
    Langley RJ; McFadzean J; McCormack J
    Paediatr Anaesth; 2016 Jan; 26(1):109-11. PubMed ID: 26456087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of sugammadex to reverse rocuronium in a patient with myotonic dystrophy.
    Petrovski J
    Anaesth Intensive Care; 2011 May; 39(3):505-6. PubMed ID: 21678593
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-establishment of neuromuscular block by rocuronium after sugammadex administration.
    Fabregat-López J; Veiga-Ruiz G; Dominguez-Serrano N; García-Martinez MR
    Can J Anaesth; 2011 Jul; 58(7):658. PubMed ID: 21468657
    [No Abstract]   [Full Text] [Related]  

  • 7. Population pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade.
    Kleijn HJ; Zollinger DP; van den Heuvel MW; Kerbusch T
    Br J Clin Pharmacol; 2011 Sep; 72(3):415-33. PubMed ID: 21535448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex.
    Drobnik L; Sparr HJ; Thörn SE; Khuenl-Brady KS; Rietbergen H; Prins ME; Ullman J
    Eur J Anaesthesiol; 2010 Oct; 27(10):866-73. PubMed ID: 20523215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block. Comment on Br J Anaesth 2024; 132: 45-52.
    Miyazaki Y; Suzuki K; Sunaga H
    Br J Anaesth; 2024 Apr; 132(4):820-821. PubMed ID: 38296751
    [No Abstract]   [Full Text] [Related]  

  • 12. Repeat dosing of rocuronium after reversal of neuromuscular block by sugammadex.
    Matsuki G; Takahata O; Iwasaki H
    Can J Anaesth; 2011 Aug; 58(8):769-70. PubMed ID: 21614668
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys.
    Bostan H; Kalkan Y; Tomak Y; Tumkaya L; Altuner D; Yılmaz A; Erdivanli B; Bedir R
    Ren Fail; 2011; 33(10):1019-24. PubMed ID: 22013936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery].
    Øberg E; Claudius C
    Ugeskr Laeger; 2013 Feb; 175(7):428-32. PubMed ID: 23402253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of rocuronium and sugammadex in an anticipated difficult airway scenario.
    McTernan CN; Rapeport DA; Ledowski T
    Anaesth Intensive Care; 2010 Mar; 38(2):390-2. PubMed ID: 20369780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restrictive versus unrestrictive use of sugammadex for reversal of rocuronium: a decision analysis.
    Lin CJ; Eikermann M; Mahajan A; Smith KJ
    Br J Anaesth; 2024 Feb; 132(2):415-417. PubMed ID: 38104004
    [No Abstract]   [Full Text] [Related]  

  • 18. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia.
    Kessell G; Trapp JN
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):394; author reply 394-5. PubMed ID: 22221068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.